Top 14 Life Science companies in Stockholm, Stockholms Lan, Sweden
Meet the trailblazing entities significantly contributing to the growth and evolution of this sector.
Hennepin Life Sciences is a growth stage human and animal health company that is uniquely focused on the development of patent protected, novel, naturally-derived anti-infective compounds for the prevention and treatment of a wide array of infections. We created innovative nature-based therapies by combining molecular concepts of infection to clinical applications.Founded in 2009 from a technology transfer out of the University of Minnesota, Hennepin Life Sciences (HLS) is a Phase2 clinical trial stage, Minnesota -based biotechnology firm that continues to develop a patented approach to address the global super bug challenge. Today, HLS continues to expand its product platform intellectual property, advance the practical science through clinical studies and is active forging distribution partnerships to initially reach clinical application.
Reluceo is developing novel functional polymers and biodegradable plastics that will replace environmentally harmful components of major consumer products.
Geissler is a biotech business that concentrates on finding and evaluating innovations with potential uses in the veterinary science sector. They produce and develop technologies that are packaged as a new product pipeline and marketed to companies so that they may include them in their product offerings. They also use their skills to carefully introduce this technology to the market. They create artificial antibodies, optical imaging, and radio frequency identification.
Invent Biotechnologies is the researcher and inventor of spin column-based technology for protein extraction and cell fractionation. Their minute kits replace all solution-based sample preparation procedures to become the laboratory standard, providing researchers with consistent results and data using a benchtop centrifuge.
MetaModix manufactures surgical and medical instruments for the treatment of metabolic diseases and Type II diabetes. The company's first product, the EndoSleeve, is designed to be a safer and more cost-effective treatment option for patients suffering from type 2 diabetes, NASH, and obesity. It was founded in 2009 and is headquartered in Plymouth, Minnesota, United States.